NEUROONE MEDICAL TECHNOLOGIES Corp CEO Dave Rosa's 2023 pay slips 17% to $990K
NEUROONE MEDICAL TECHNOLOGIES Corp reports 2023 executive compensation
By ExecPay News
Published: January 29, 2024
NEUROONE MEDICAL TECHNOLOGIES Corp reported fiscal year 2023 executive compensation information on January 29, 2024.
In 2023, three executives at NEUROONE MEDICAL TECHNOLOGIES Corp received on average a compensation package of $612K, a 6% decrease compared to previous year.
Average pay of disclosed executives at NEUROONE MEDICAL TECHNOLOGIES Corp
Dave Rosa, Chief Executive Officer, received $990K in total, which decreased by 17% compared to 2022. 51% of Rosa's compensation, or $507K, was in salary. Rosa also received $253K in non-equity incentive plan, $84K in option awards, as well as $145K in stock awards.
Steve Mertens, Chief Technology Officer, received a compensation package of $458K, which increased by 16% compared to previous year. 58% of the compensation package, or $266K, was in salary.
Ron McClurg, Chief Financial Officer, earned $390K in 2023, a 4% increase compared to previous year.
NEUROONE MEDICAL TECHNOLOGIES Corp's fiscal year ends on September 30.
Related executives
You may also like
Source: SEC filing on January 29, 2024.